Nephrotic syndrome IN CHILDREN Lecture for MBBS

drsajjadsabir 8,694 views 41 slides Sep 13, 2017
Slide 1
Slide 1 of 41
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41

About This Presentation

Nephrotic syndrome IN CHILDREN FOR UNDER GRADUATES


Slide Content

Dr. Muhammad Sajjad Sabir
MBBS, DCH, MCPS, FCPS
Assistant Professor of Paediatrics

Manifestation of glomerular disease,
characterized by nephrotic range
proteinuria and a triad of clinical
findings associated with large urinary
losses of protein : hypoalbuminaemia ,
edema and hyperlipidemia

Edema
Heavy proteinuria > 40mg/m2/hr
Hypoalbuminemia <2.5g/dl
Hyperlipidema >250mg/dl

15 x more common in children than adults
2 – 7 cases / 100,000 children / year (Global)
Incidence South Asia 16/100,000 children
Most common= 1.5 - 6 year
boys : girls --- 2:1

Defined as
Protein excretion of > 40 mg/m
2
/hr
(>1g/m
2
/24 hr)
Spot Protein : Creatinine > 2-3 : 1
(First morning urine sample)

- Nelson Textbook of Paediatrics, Vol 2, 19
th
Edition, page 1801

Idiopathic or Primary
Genetic
Secondary

Minimal Change disease ( >80 % )
Mesangial proliferation
Focal segmental Glomerulosclerosis
Membranous Nephropathy
Membranoproliferative glomerulonephritis
- Nelson Textbook of Paediatrics, Vol 2, 19
th
Edition, page 1804

Finnish type Cong. Nephrotic
Syndrome
Focal Segmental
Glomerulosclerosis
Diffuse Mesangial Sclerosis
Denys-Drash Syndrome
- Nelson Textbook of Paediatrics, Vol 2, 19
th
edition, page 1802, table 521-1

Congenital--Oligomeganephronia
Infectious--Hepatitis (B,C) , HIV-1, Malaria,
Syphilis, Toxoplasmosis
Inflammatory--Glomerulonephritis
Immunological--Castleman Disease,Bee sting,
Food allergens
Neoplastic--Lymphoma, Leukemia
Traumatic ( Drug induced )--Penicillamine,
Gold, NSAIDS, Pamidronate, Mercury, Lithium

Preceding flu-like illness
General health
(anorexia, weight gain ,lethargy)
Edema
Urinary symptoms
(hematuria, oliguria)
Infection, diarrhea, abd. pain
Drug intake
Past history

Periorbital puffiness

Edema
Mild early – periorbital puffiness, lower extremities
Progression to gen. edema, ascites, pleural
effusion, genital edema
Decreased urine output
Anorexia, Irritability, Abdominal pain and diarrhoea
Vital & BP
Height & weight for age
Anemia
- Nelson Textbook of Paediatrics, Vol 2, 19
th
Edition, page 1802
Clinical Features-Examination
 No Hypertension
 No Gross hematuria

CLINICAL FEATURES Minimal Change
Nephrotic Syndrome
Focal Segmental
Glomerulosclerosis
Membranous
Nephropathy
Age ( yr ) 2 - 6 2 - 10 40 - 50
Sex ( M : F ) 2 : 1 1.3 : 1 2 : 1
Nephrotic
Syndrome
100 % 90 % 80 %
Asymptomatic
proteinuria
0% 10 % 20 %
Hematuria 10 – 20 % 60 – 80 % 60 %
Hypertension 10 % 20 % earlyInfrequent
Rate of
progression to
renal failure
Non
progressive
10 yrs 50 % in 10 – 20
yrs
Associated
Conditions
Usually noneNone Renal vein
thrombosis, SLE,
Hepatitis B

URINE ANALYSIS
PROTEINURIA: 3+ Or 4+
MICROSCOPIC HEMATURIA: 20%
PUS CELLS:underlying UTI
CELLULAR CASTS: not in minimal change
disease
Trace /nil (10-20mg/dl)
+ (30mg/dl)
++ (100mg/dl)
+++(300mg/dl)
++++(1000-2000mg/dl)

24HRS URINARY PROTEIN EXCRETION:
Children : >40mg/m2/hr
(>1g/m
2
/24 hr)
URINARY spot PROTEIN : CREATININE > 2.0
(Spot UPC ratio > 2.0)

SERUM
S. CREATININE:Normal
S. CHOLESTROL:↑ >250mg/dl
S. ALBUMIN: <2.5g/dl
C3 & C4: Normal
TOTAL CALCIUM:Decreased

VITRAL SEROLOGY:
HBV associated with membranous nephritis
BLOOD COUNTS:
Hb, TLC & DLC Normal
ESR raised
X-RAY CHEST:
R/O pulmonary TB
R/O pleural effusion

MANTOUX TEST:
R/O TB before starting steroids
ANA:R/O SLE
• Age below 12 months
• Gross or persistent microscopic hematuria
• Low blood C3
• Hypertension
• Impaired renal Function
• Failure of steroid therapy fiBsC astiPFF/tHFbSi uFmstnPw
Indications for Renal biopsy

Protein losing enteropathy
Hepatic failure
Heart failure
Acute/Chronic Glomerulonephritis
Protein Malnutrition

Other forms of glomerulonephritis
Pyelonephritis
Obstructive Uropathies
Hemolytic Uremic Syndrome
Fever
Exercise
Orthostatic proteinurea
Renal Failure
Congestive cardiac failure
Liver failure

Management

DIETARY ADVICE:
Balanced diet = adequate proteins & calories
Foods high in sodium avoided
High protein diet
Edema no added salt
Treatment of infections
Parent Education
Can attend school
Can participate in physical activities as tolerated

If significant edema
 Diuretics + Aldosterone antagonist
( Fursemide, spironolactone )
Salt restriction
DIURETICS INDICATIONS:
Severe symptomatic edema
Steroid toxicity or steroid contraindicated
Q.Best diuretic in Nephrotic Syndrome?

ROLE OF INTRAVENOUS ALBUMIN
INDICATIONS:
Signs of hypovolemia
Sever oedema
DOSAGE & ADMINISTRATION:
I/V salt poor 25% albumin infusion
0.5-1 gm/kg/dose over 6-12 hrs + I/V
Frusemide 1-2 mg/kg

DOSAGE & ADMINISTRATION:(after a -ve PPD test)
Prednisolone 60mg/m
2
/day (max 80mg)
As single am daily dose {or 2-3 dd} for 6 wks
After the initial 6-wk course,
Prednisone dose tapered to 40 mg/m
2
/day given
every other day as a single daily dose for at
least 6 wk.
Alternate-day dose then slowly
tapered→discontinued over next 1-2 mo

Response means
Clinical remission
Diuresis , and
Urine trace or negative for
protein for 3 consecutive days

REPONSE TO STEROID:
80-90% children respond within 3 wk
10% respond by first week
70% by second week
85% by third week
92% by forth week
Who respond to prednisone therapy
do so within first 5 wk of treatment

STEROID DEPENDENT: Patients who relapse while
on alternate-day steroid therapy or within 28 days of
completing a successful course of prednisone therapy
FREQUENT RELAPSERS: Patients who respond
well to prednisone therapy but relapse ≥ 4 times in
a 12-mo period
INFREQUENT RELAPSERS :3 or less relapses per yr
STEROID RESISTANT: Fail to respond to
corticosteroid therapy within 8 wks
Children who continue to have proteinuria (2+ or greater)
Diagnostic renal biopsy should be performed

Relapses should be treated with:
Prednisone 60 mg/m
2
/day (80 mg daily max)
As single am dose
Until child enters remission (urine trace or
negative for protein for 3 consecutive days)
Then prednisone changed to alternate-day
(40 mg/m
2
/day )
Gradually tapered over 4-8 wk

ALTERNATIVE THERAPY:
INDICATIONS:
Steroid dependent
Frequent relapsers
Steroid responsive
Unwanted effects of steroids

Alternate Day prednisolone
Steroid sparing agents
 Levamisole ( 2 – 2.5 mg/kg )
Cyclophosphamide ( 2 – 2.5 mg/kg/day)
Mycophenolate Mofetil (20 – 25 mg/kg/day)
Cyclosporin ( 4 – 5 mg/kg/day )
Tacrolimus (0.1 – 0.2 mg/kg/day )
Rituximab ( 375mg/m
2
IV once a week )

INFECTIONS:
SBP
Pneumonia
Cellulitis
UTI
Disseminated varicella
THROMBOEMBOLISM:
Renal vein thrombosis
Pulmonary embolism
Saggital sinus thrombosis
OTHERS:
Acute renal failure
Hypertension
Malnutrition
Flare up of tuberculosis
Steroid & drug related
toxicity

Blood CP
Urine RE
Growth parameters
General examination
Blood Pressure
Eye examination
RFTs
Serum electrolytes
BSR
Serum calcium
X-Ray wrist
X-Ray spine
Chest X-Ray
PT/APTT

Steroid Responsive NS : Good prognosis
( MCNS )
Steroid Resistant NS : Poor prognosis
( FSGS )
Mortality rate 1-2 %
- Nelson Textbook of Paediatrics, Vol 2, 19
th
Edition, page 1806

DEFINITION:
Infants who develop nephrotic syndrome
within first 3 months of life
ETIOLOGY:
Finish type congenital nephrotic syndrome
Congenital infections
HIV/HBV
Diffused mesengial sclerosis
Drash syndrome

TREATMENT:
ACE inhibitors + Indomethacin + unilateral neprectomy
B/L nephrectomy →Chronic dialysis & Renal transplant
no role of steroid or immunosuppressive agents
PROGNOSIS:
Poor
Progressive renal failure
Death by 5 yrs age if untreated